Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serum
- 28 December 1992
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 47 (3), 245-252
- https://doi.org/10.1016/0028-2243(92)90159-v
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Use of Serum Tumor Markers in the Differential Diagnosis between Ovarian and Colorectal AdenocarcinomasTumor Biology, 1992
- Interlaboratory Survey of Methods for Measuring Human Anti-Mouse AntibodiesClinical Chemistry, 1992
- Coordinate elevation of serum markers in ovarian cancer but not in benign diseaseCancer, 1991
- Prospective evaluation of serum CA 125 levels in a normal population, phase I: The specificities of single and serial determinations in testing for ovarian cancerGynecologic Oncology, 1990
- The CA 125 tumour-associated antigen: a review of the literatureHuman Reproduction, 1989
- Correlation of an enzyme immunoassay with the radioimmunoassay for CA-125American Journal of Obstetrics and Gynecology, 1988
- Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assaysInternational Journal of Cancer, 1988
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983